Mindset Continues to Thrive Collaborating with Big Pharma‪!‬ The Investors Coliseum Groundbreaking Podcast Series, Sharing Opinions & Perspectives from the Pros

On Today’s Quick Cast we catch up with James Lanthier (CEO, Mindset Pharma) to discuss the latest in their ongoing collaborative efforts with Otsuka Pharmaceutical.  James also will be providing investors and listeners for some key industry insight along with what catalysts we can expect in the coming months.

ABOUT MINDSET PHARMA INC. (CSE: MSET) (FSE:9DF) (OTCQB: MSSTF)

Mindset Pharma is a Toronto-based drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders.

Please visit for a Full Profile View and Press Release of Mindset Pharma Inc. https://theinvestorscoliseum.com/featured-companies/mindset-pharma-inc/

#psychedelics #psychedelicscience #psychedelicresearch #psychedelictherapy #healthandwellness #cannabis #mset #mindsetpharma #cse #psilocybin #psychedelicmedicine #medicine #clinicalresearch #research #lifesciences #biotech #pharma #biotechnology #therapy #addiction #microdose #ptsd #mentalhealth #etf #nyse #drugdevelopment #drugdiscovery #neuroscience #community #mindset #data